ALMS (Alumis Inc.) חוב לטווח קצר להון

Alumis Inc. (ALMS) relies on external contractors for drug development and testing to minimize infrastructure costs. The brand maintains high status due to its progressive methods for treating systemic lupus erythematosus and psoriasis. The logistics model is based on distributing orders across various plants to prevent disruptions. The current metric stands at 0.01, and the daily price action is illustrated in the chart below.

The full capacity of Alumis Inc. research centers and contract manufacturing makes the short-term debt-to-equity ratio on GURU.Markets a key indicator of financial stability. This metric compares liabilities with maturities of up to one year against the amount of equity to assess liquidity. An increase in this value signals a rising credit burden, while a decrease indicates strengthening financial autonomy. It is critical for investors to maintain a balance between aggressive growth and default risk.